Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 308.50
-11.50 (-3.59%)
At close: Oct 1, 2026
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 87.17 billion as of October 2, 2026. Its market cap has increased by 88.45% in one year.
Market Cap
87.17B
Enterprise Value
82.16B
Revenue
88.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
308.50
ChartMarket Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 87.17B, an increase of 5,309.29%. That is a compound annual growth rate of 17.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 87.17B | 129.67% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 274.47B |
| Shilpa Medicare | 208.03B |
| Symbiotec Pharmalab | 76.98B |
| IOL Chemicals and Pharmaceuticals | 61.48B |
| Gujarat Themis Biosyn | 49.76B |
| NGL Fine-Chem | 17.97B |
| Bajaj HealthCare | 10.98B |
| Shree Ganesh Remedies | 8.81B |